中国药师
中國藥師
중국약사
CHINA PHARMACIST
2015年
8期
1269-1273
,共5页
陈晨%王秋婷%杨仕军%赵欣%李晓亚%林余霖%蔡大勇
陳晨%王鞦婷%楊仕軍%趙訢%李曉亞%林餘霖%蔡大勇
진신%왕추정%양사군%조흔%리효아%림여림%채대용
清毒颗粒%抗肿瘤%免疫调节
清毒顆粒%抗腫瘤%免疫調節
청독과립%항종류%면역조절
Qingdu granules%Antitumor%Immunoregulation
目的::探讨清毒颗粒对二甲基苯蒽( DMBA)诱导SD大鼠乳腺癌的药效。方法:DMBA诱导大鼠乳腺癌,观察清毒颗粒对肿瘤抑制率,HE染色观察病理特点,IHC检测肿瘤组织Ki-67分布及含量,ELISA检测大鼠血清中IL-12、IFN-γ、IL-4和IL-10含量。结果:低、中、高剂量清毒颗粒和柴胡皂苷a的抑瘤率分别为:30.93%,43.84%,44.17%和43.48%;清毒颗粒和柴胡皂苷a可显著降低Ki-67表达量;上调血清中IL-12、IFN-γ含量,下调IL-4、IL-10含量。结论:清毒颗粒具有抗乳腺癌作用,其机制可能是调节机体免疫,增强抗肿瘤免疫作用。
目的::探討清毒顆粒對二甲基苯蒽( DMBA)誘導SD大鼠乳腺癌的藥效。方法:DMBA誘導大鼠乳腺癌,觀察清毒顆粒對腫瘤抑製率,HE染色觀察病理特點,IHC檢測腫瘤組織Ki-67分佈及含量,ELISA檢測大鼠血清中IL-12、IFN-γ、IL-4和IL-10含量。結果:低、中、高劑量清毒顆粒和柴鬍皂苷a的抑瘤率分彆為:30.93%,43.84%,44.17%和43.48%;清毒顆粒和柴鬍皂苷a可顯著降低Ki-67錶達量;上調血清中IL-12、IFN-γ含量,下調IL-4、IL-10含量。結論:清毒顆粒具有抗乳腺癌作用,其機製可能是調節機體免疫,增彊抗腫瘤免疫作用。
목적::탐토청독과립대이갑기분은( DMBA)유도SD대서유선암적약효。방법:DMBA유도대서유선암,관찰청독과립대종류억제솔,HE염색관찰병리특점,IHC검측종류조직Ki-67분포급함량,ELISA검측대서혈청중IL-12、IFN-γ、IL-4화IL-10함량。결과:저、중、고제량청독과립화시호조감a적억류솔분별위:30.93%,43.84%,44.17%화43.48%;청독과립화시호조감a가현저강저Ki-67표체량;상조혈청중IL-12、IFN-γ함량,하조IL-4、IL-10함량。결론:청독과립구유항유선암작용,기궤제가능시조절궤체면역,증강항종류면역작용。
To study the effect and mechanism of Qingdu granules on the tumor growth of 7, 12-dimethyl-benz[ a] an-thracene ( DMBA)-induced breast cancer in Sprague-Dawley rats. Methods: DMBA was used to induce breast cancer in rats. The tumor inhibition of Qingdu granules was observed. Pathological features were observed after hematoxylin-eosin staining, the distribution and content of Ki-67 in tumor were tested by IHC and the content of IL-12, IFN-γ, IL-4 and IL-10 in serum was determined by ELISA. Results:The inhibitory rate of Qingdu granules at low, middle and high dose and saikosaponin a was 30. 93%,43. 84% and 44. 17% and 43. 48%, respectively. The expression of Ki-67 was reduced in Qingdu granules groups and saikosaponin a group, the content of IL-12 and IFN-γ in serum was increased and the level of IL-4 and IL-10 was reduced in the above groups. Conclusion:Qingdu granules can inhibit breast cancer obviously, and the mechanism is probably related to the ability of immune system adjustment, which can enhance the antitumor effect.